CSJ117
CCSJ117A12201E1
Phase 2 small_molecule terminated
Quick answer
CSJ117 for Asthma is a Phase 2 program (small_molecule) at Novartis Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated